Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|July 18, 2014
Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomesMichael K Wong, Howard L Kaufman, Gregory A Daniels, et al.Current Medical Research and Opinion|December 17, 2013
Comparative outcomes of everolimus, temsirolimus and sorafenib as second targeted therapies for metastatic renal cell carcinoma: a US medical record reviewMichael K Wong, Hongbo Yang, James E Signorovitch, et al.Virology|March 11, 2014
Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotypeDiane M Da Silva, Carly A Movius, Adam B Raff, et al.Biomaterials|February 5, 2013
Crosslinked multilamellar liposomes for controlled delivery of anticancer drugsKye-Il Joo, Liang Xiao, Shuanglong Liu, et al.JAMA Ophthalmology|October 20, 2022
A Geographic Analysis of Google Characterizations of Who Is an "Eye Doctor" Across the USRebecca R Soares, Ankur Nahar, Raziyeh Mahmoudzadeh, et al.Journal of Neurosurgery|December 2, 2016
Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgeryShelly X Bian, David Routman, Jonathan Liu, et al.Journal of Neuro-Oncology|April 27, 2018
Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicityKevin Diao, Shelly X Bian, David M Routman, et al.Journal of Alzheimer'S Disease : JAD|October 2, 2013
Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and strokeMaire Percy, Martin J Somerville, Mark Hicks, et al.Journal of Neurosurgery|January 6, 2018
Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effectsKevin Diao, Shelly X Bian, David M Routman, et al.Journal of Registry Management|June 1, 2023
The Merkel Cell Carcinoma Patient Registry: From Promise to Prototype to PatientDavid M Miller, Sophia Z Shalhout, Farees Saqlain, et al.Pageof 10